3rd Circuit Overturns Merck’s Preemption Win In Fosamax Cases
PHILADELPHIA — A Third Circuit U.S. Court of Appeals panel on March 22 reversed a federal judge in New Jersey’s ruling awarding summary judgment to the maker of the osteoporosis drug...To view the full article, register now.
Already a subscriber? Click here to view full article